Commercial lead for Amplify, the early-stage translational fund of Mass General Brigham Innovation.Amplify provides technical and strategic expertise and funding resources to advance promising pre-commercial technologies, focusing on discoveries from Investigators at the Mass General Brigham (MGB) hospitals.

Consulting services for early-stage biotechnology startups including operations, IT, and strategy.

As a member of the life sciences strategy consulting staff at Putnam, I collaborated with partners, colleagues, clients, and stakeholders to synthesize concrete and actionable recommendations to answer client key business questions (KBQs). Our teams worked to create compelling deliverables to message our process and conclusions, and present our findings in a clear, concise, and eloquent way. - Interacted with clients to understand problems, and develop and refine hypotheses to test- Structured complex strategic and analytical problems that constitute the core of the team’s work- Leveraged scientific and business background to optimize commercial strategies for clients- Synthesized analyses into key findings and actionable recommendations

Represented science since Day 1 of venture backed biotech startup — generating decision-driving data and operationalizing a prolific research organization. Contributed to the growth of the company to a publicly traded clinical-stage biotechnology firm.- Project Lead for multiple preclinical research projects. Coached and mentored on strategy.- Prepared reports for regulatory submission while building R&D knowledge base.- Presented work at major conferences to broaden commercial awareness of the firm.- Executed preclinical efficacy and safety studies, while learning and teaching drug development.- Created compelling deliverables for presentation by ELT to VC partners and funders.- Contributed to multiple patent applications—composing materials and methods sections.

Associate research scientist in Preclinical Imaging and Pharmacology group with focuses on in-vivo nuclear imaging including PET/CT (Siemens Inveon), SPECT/CT (Mediso NanoSPECT), in-vivo Bioluminescent imaging (PerkinElmer IVIS Spectrum), and ex-vivo/in-vitro pharmacology.